The 20 Best Chromophobe Renal Cell Carcinoma Doctors Near Me in Yonkers, NY

Ketan Badani is a Urologist in New York, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Thomas Rechtschaffen is a Urologist in Yonkers, New York. Dr. Rechtschaffen is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Interstitial Cystitis, Enlarged Prostate (BPH), UPJ Obstruction, Ureteroscopy, and Prostatectomy.

Ahmed Aboumohamed, MD is an Attending Physician and a Professor in the Department of Urology at Montefiore and our Albert Einstein College of Medicine. Dr. Aboumohamed's areas of expertise include urology, urologic oncology, minimally invasive and robotic surgery, and urologic reconstruction. Dr. Aboumohamed is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bilateral Hydronephrosis, Bladder Cancer, Hydronephrosis, Cystectomy, and Nephrectomy.

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Marc Janis is a Urologist in Mount Vernon, New York. Dr. Janis is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Male Pseudohermaphroditism with Gynecomastia, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Ureteroscopy, and Prostatic Artery Embolization.

Michael Stifelman is a Urologist in Hackensack, New Jersey. Dr. Stifelman is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), UPJ Obstruction, Retroperitoneal Fibrosis, Nephrectomy, and Ureteral Reconstruction.

Robert Alter is an Otolaryngologist in Hackensack, New Jersey. Dr. Alter is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Mutahar Ahmed is a Urologist in Maywood, New Jersey. Dr. Ahmed is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Ureterocele, Nephrectomy, and Ureteral Reconstruction.

Gregory Lovallo is an Oncologist in Maywood, New Jersey. Dr. Lovallo is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Obstructive Uropathy, Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Nephrectomy, and Reconstructive Urology Surgery.

John Sfakianos is a Urologist in Astoria, New York. Dr. Sfakianos is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Sfakianos is currently accepting new patients.

Paul Russo is a Urologist in New York, New York. Dr. Russo is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery. Dr. Russo is currently accepting new patients.

Martin Voss is an Oncologist in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Voss is currently accepting new patients.

Jonathan Coleman is a Urologist in New York, New York. Dr. Coleman is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy. Dr. Coleman is currently accepting new patients.

Abraham Hakimi is a Urologist in New York, New York. Dr. Hakimi is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hakimi is currently accepting new patients.

Robert Motzer is an Oncologist in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy. Dr. Motzer is currently accepting new patients.

Norman Rosen is an Oncologist in Yonkers, New York. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, GTP Cyclohydrolase 1 Deficiency, Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency, and Bone Marrow Aspiration.

Sol Usher is a Urologist in Yonkers, New York. Dr. Usher is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Malakoplakia.

Eric Margolis is a Urologist in Englewood, New Jersey. Dr. Margolis is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Enlarged Prostate (BPH), Frequent or Urgent Urination, Urinary Incontinence, Ureteroscopy, and Prostatectomy.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.